Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

223 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Monitoring the safety of drugs and COVID-19 vaccines by the French Pharmacovigilance Centers during the pandemic: a win-win bet with Health Authorities!].
Jonville-Bera AP, Gautier S, Micallef J, Massy N, Atzenhoffer M, Drici MD, Grandvuillemin A; Réseau français des centres régionaux de pharmacovigilance. Jonville-Bera AP, et al. Therapie. 2023 Sep-Oct;78(5):477-488. doi: 10.1016/j.therap.2023.02.009. Epub 2023 Feb 22. Therapie. 2023. PMID: 36890032 Free PMC article. French.
Monitoring the safety of drugs and COVID-19 vaccines by the French Pharmacovigilance Centers during the pandemic: A win-win bet with Health Authorities!
Jonville-Bera AP, Gautier S, Micallef J, Massy N, Atzenhoffer M, Grandvuillemin A, Drici MD; French Network of Regional Pharmacovigilance Centres. Jonville-Bera AP, et al. Therapie. 2023 Sep-Oct;78(5):467-475. doi: 10.1016/j.therap.2023.03.002. Epub 2023 Mar 7. Therapie. 2023. PMID: 37012154 Free PMC article.
Are clinical data from spontaneous pharmacovigilance reports transmitted via the Ministry of Health's web portal sufficient to generate a signal without further documentation?
Grandvuillemin A, Jeannot A, Valnet-Rabier MB, Pietri T, Chouchana L, Gautier S, Jonville Bera AP; French Regional Pharmacovigilance Network. Grandvuillemin A, et al. Among authors: jonville bera ap. Therapie. 2024 Jul-Aug;79(4):493-496. doi: 10.1016/j.therap.2023.10.006. Epub 2023 Oct 31. Therapie. 2024. PMID: 37957051 No abstract available.
The enhanced national pharmacovigilance system implemented for COVID-19 vaccines in France: A 2-year experience report.
Crommelynck S, Grandvuillemin A, Ferard C, Mounier C, Gault N, Pierron E, Jacquot B, Vaillant T, Chatelet IPD, Jacquet A, Salvo F, Alt M, Bagheri H, Micallef J, Pariente A, Gautier S, Valnet-Rabier MB, Atzenhoffer M, Lepelley M, Cottin J, Lacroix I, Gras V, Massy N, Dhanani A, Vella P, Shaim Y, Baril L, Jonville-Béra AP, Benkebil M; 30 French Regional Pharmacovigilance Centres. Crommelynck S, et al. Among authors: jonville bera ap. Therapie. 2024 Nov 14:S0040-5957(24)00199-9. doi: 10.1016/j.therap.2024.11.002. Online ahead of print. Therapie. 2024. PMID: 39638686 Free article.
Indication for a Pneumocystis Prophylaxis Therapy in Patients with Vascular Anomalies Treated with PIK3/AKT/mTOR Pathway Inhibitors: Experts' Opinion and Systematic Review from the Literature.
Navarro M, Allemang-Trivalle A, Leducq S, Jonville-Bera AP, Maurier A, Zejli T, Edée AE, Harchaoui E, Giraudeau B, Maruani A. Navarro M, et al. Among authors: jonville bera ap. Dermatology. 2023;239(6):942-951. doi: 10.1159/000533675. Epub 2023 Oct 4. Dermatology. 2023. PMID: 37793356 Free article.
223 results